The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.00
Bid: 22.00
Ask: 24.00
Change: 0.00 (0.00%)
Spread: 2.00 (9.091%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 23.00
CKT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Feb 2024 07:00

RNS Number : 1219D
Checkit PLC
15 February 2024
 

15 February 2024

 

Checkit plc

("Checkit" or the "Group)

 

FY24 Trading Update

 

Checkit (AIM: CKT), the intelligent operations platform for the deskless worker, announces its unaudited trading update for the year ended 31 January 2024 ("FY24").

 

· Annual recurring revenue ("ARR"1) growth of 16% to £13.3m, in line with expectations

· Focus on path to profitability is anticipated to result in better than expected losses ("LBITDA"2) halving year-on-year to £3.4m

· Recurring revenues provide good visibility for future periods underpinned by a high net revenue retention3 of 111%

 

(£'m) Reported

Twelve months to

 

31 January 2024

31 January 2023

% Change

ARR

13.3

11.5

16%

 

 

 

 

Revenue

 

 

 

Recurring

11.2

9.6

+17 %

Non-recurring

0.8

0.7

+18 %

Total Group

12.0

10.3

+17 %

 

 

 

 

 

Kit Kyte, CEO of Checkit, commented: "The second half of the year has seen further progress on our stated strategy and our drive towards profitability. Our new AI enhanced products are, we believe, best in class and a step change ahead of what's currently available in the market. We will continue to focus on driving top-line growth in the business and look forward to FY25 with confidence."

 

Results

 

Revenue has grown by 17% to £12.0m, in line with market expectations despite the challenging global economy. Our 'Land and Expand' strategy of up-selling and cross-selling has generated growth from our existing customer base, whilst at the same time we have actively identified areas of expansion and opportunity both geographically and vertically. With recurring revenues now representing 93% of the total and our high net revenue retention of 111%, we have a sound base to pursue our drive towards profitability.

 

Our focus on gross margin expansion continues to deliver and we expect losses (adjusted LBITDA) to be better than expected and nearly halve for the year to £3.4m (2023: LBITDA of £6.4m) as we drive operational efficiencies and carefully manage costs across the business.

 

Our cash position at the end of year was £9.0m (31 July 2023: £12.8m), reflecting the 46% reduction in LBITDA and the strategic purchase of inventory to mitigate supply chain constraints in the market. We expect this position to unwind over the next 12-18 months, supporting further revenue growth.

 

Product Update

 

During the year, utilising the data we collect and new AI and ML tools, we have successfully added new functionality to our products that will allow our customers to deliver sustainability and energy saving initiatives and benefit from predictive maintenance of their assets. This is being actively trialled by one of our largest customers and we are confident that these developments will provide significant value to the Group and our customers.

 

We have continued to invest in our products and our markets and we are gaining traction geographically, with 26% of ARR now generated in the US, and as we develop our offerings to address new sectors, such as food manufacturing and R&D laboratories.

 

We will provide further detail on our product strategy and the path to profitability at the time of our FY24 Results announcement in April 2024.

 

The Group's management team will host a live webinar which will include an opportunity for questions at 14:00 (GMT) today. The webinar can be accessed via the news area of the website at https://www.checkit.net/news/ or by using this link:

https://www.investormeetcompany.com/checkit-plc/register-investor

 

NOTES

 

1. Annual Recurring Revenue ("ARR") is defined as the annualised value of contracted recurring revenue from subscription services as at the period end, including committed annual recurring revenue from new wins.

2. Adjusted LBITDA is the loss on operating activities before depreciation and amortisation, share based payment charges and non-recurring or special items. Analysts' Adjusted LBITDA expectations for FY24 were £3.6m.

3. Net revenue retention is defined as the amount of recurring revenue from existing customers retained over the period, excluding new wins in the last year.

 

 

For further information, please visit www.checkit.net or contact:

 

Checkit plc

Kit Kyte (Chief Executive Officer)

Greg Price (Chief Financial and Operations Officer)

+44 (0) 1223 643313

Singer Capital Markets (Nominated Adviser & Broker)

Shaun Dobson / Harry Gooden / James Fischer

+44 (0) 20 7496 3000

Tavistock (Financial PR)

Lulu Bridges / Katie Hopkins / Simon Hudson

+44 (0) 20 7920 3150

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGCGDDXUBDGSS
Date   Source Headline
29th Apr 20242:59 pmRNSDirector/PDMR Shareholding
25th Apr 20247:00 amRNSFinal Results
17th Apr 20242:35 pmRNSNotice of Results and Investor Presentation
15th Apr 20247:00 amRNSNew Product Launch and Contract Wins
14th Mar 20248:49 amRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSGrant of Options and PDMR Dealings
8th Mar 20249:00 amRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSTrading Update
5th Feb 20247:00 amRNSInvestor Presentation
1st Feb 20242:25 pmRNSSurrender of Existing Options
7th Nov 20237:00 amRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSInterim Results
24th Aug 20237:00 amRNSInvestor Presentation
10th Aug 20237:00 amRNSTrading update notice of results & contract
8th Jun 20234:08 pmRNSResult of AGM
24th May 20233:29 pmRNSDirector/PDMR Shareholding
15th May 20231:04 pmRNSPosting of Annual Report and Notice of AGM
24th Apr 20237:00 amRNSPreliminary Results
13th Apr 20231:36 pmRNSNotice of Results and Investor Presentation
23rd Mar 20235:25 pmRNSDirector/PDMR Shareholding
13th Mar 20238:55 amRNSStatement re. Silicon Valley Bank
16th Feb 20237:00 amRNSTrading Update and Notice of Results
26th Jan 20234:10 pmRNSDirectorate Change
23rd Jan 20237:00 amRNSDirector/PCA Dealing
10th Jan 20237:00 amRNSAppointment of Non-Executive Director
10th Jan 20237:00 amRNSGrant of options and PDMR dealings
5th Jan 20237:00 amRNSContract wins and investor presentation
12th Dec 20225:14 pmRNSDirector/PDMR Shareholding
27th Sep 202212:28 pmRNSHolding(s) in Company
23rd Sep 20226:16 pmRNSDirector/PDMR Shareholding
16th Sep 20225:36 pmRNSDirector Dealing
15th Sep 20227:00 amRNSInterim Results
6th Sep 20227:00 amRNSInvestor Presentation
22nd Aug 20221:07 pmRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSTrading Update and Notice of Interim Results
9th Jun 20223:09 pmRNSResult of AGM
13th May 20225:17 pmRNSPosting of Annual Report and Notice of AGM
13th May 20227:00 amRNSInvestor Conference
4th May 20227:00 amRNSContract Renewal
28th Apr 20227:00 amRNSPreliminary Results
29th Mar 20227:00 amRNSGrant of options and PDMR dealings
23rd Feb 20227:00 amRNSPDMR Dealing
22nd Feb 20227:00 amRNSPDMR Dealing
17th Feb 20227:00 amRNSTrading update
1st Feb 20227:00 amRNSContract win
22nd Dec 20212:06 pmRNSHolding(s) in Company
20th Dec 20217:01 amEQSCheckit (CKT): SaaS software for the deskless workforce
17th Dec 20212:44 pmRNSDirector/PDMR Shareholding
16th Dec 202111:52 amRNSResult of General Meeting and Admission
2nd Dec 202111:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.